Cargando…
Bilateral Inflammatory Breast Cancer That Developed Two Years after Treatment for Triple-negative Breast Cancer
A 66-year-old woman underwent partial mastectomy and a sentinel lymph node biopsy for left breast cancer; the pathological diagnosis was invasive ductal carcinoma (pT1aN0, pStage I, triple-negative subtype). Postoperative radiotherapy was performed. Two years later, she developed redness and indurat...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424078/ https://www.ncbi.nlm.nih.gov/pubmed/35022341 http://dx.doi.org/10.2169/internalmedicine.7786-21 |
_version_ | 1784778161323507712 |
---|---|
author | Kawaguchi, Yuta Kuba, Sayaka Morita, Michi Meng, Xiangyue Hayashi, Hiroko Kobayashi, Kazuma Adachi, Tomohiko Hidaka, Masaaki Itoh, Shinichiro Kanetaka, Kengo Eguchi, Susumu |
author_facet | Kawaguchi, Yuta Kuba, Sayaka Morita, Michi Meng, Xiangyue Hayashi, Hiroko Kobayashi, Kazuma Adachi, Tomohiko Hidaka, Masaaki Itoh, Shinichiro Kanetaka, Kengo Eguchi, Susumu |
author_sort | Kawaguchi, Yuta |
collection | PubMed |
description | A 66-year-old woman underwent partial mastectomy and a sentinel lymph node biopsy for left breast cancer; the pathological diagnosis was invasive ductal carcinoma (pT1aN0, pStage I, triple-negative subtype). Postoperative radiotherapy was performed. Two years later, she developed redness and induration at both breasts. The diagnosis was bilateral inflammatory breast cancer. After four cycles of dose-dense epirubicin and cyclophosphamide followed by 12 weekly paclitaxel cycles, bilateral total mastectomy and axillary lymph node dissection were performed. At the one-year follow-up after undergoing operation and radiotherapy, she remained alive without recurrence. Dose-dense treatment regimens may help patients achieve complete resection without short-term recurrence. |
format | Online Article Text |
id | pubmed-9424078 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Japanese Society of Internal Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-94240782022-09-15 Bilateral Inflammatory Breast Cancer That Developed Two Years after Treatment for Triple-negative Breast Cancer Kawaguchi, Yuta Kuba, Sayaka Morita, Michi Meng, Xiangyue Hayashi, Hiroko Kobayashi, Kazuma Adachi, Tomohiko Hidaka, Masaaki Itoh, Shinichiro Kanetaka, Kengo Eguchi, Susumu Intern Med Case Report A 66-year-old woman underwent partial mastectomy and a sentinel lymph node biopsy for left breast cancer; the pathological diagnosis was invasive ductal carcinoma (pT1aN0, pStage I, triple-negative subtype). Postoperative radiotherapy was performed. Two years later, she developed redness and induration at both breasts. The diagnosis was bilateral inflammatory breast cancer. After four cycles of dose-dense epirubicin and cyclophosphamide followed by 12 weekly paclitaxel cycles, bilateral total mastectomy and axillary lymph node dissection were performed. At the one-year follow-up after undergoing operation and radiotherapy, she remained alive without recurrence. Dose-dense treatment regimens may help patients achieve complete resection without short-term recurrence. The Japanese Society of Internal Medicine 2022-01-13 2022-08-01 /pmc/articles/PMC9424078/ /pubmed/35022341 http://dx.doi.org/10.2169/internalmedicine.7786-21 Text en Copyright © 2022 by The Japanese Society of Internal Medicine https://creativecommons.org/licenses/by-nc-nd/4.0/The Internal Medicine is an Open Access journal distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view the details of this license, please visit (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Kawaguchi, Yuta Kuba, Sayaka Morita, Michi Meng, Xiangyue Hayashi, Hiroko Kobayashi, Kazuma Adachi, Tomohiko Hidaka, Masaaki Itoh, Shinichiro Kanetaka, Kengo Eguchi, Susumu Bilateral Inflammatory Breast Cancer That Developed Two Years after Treatment for Triple-negative Breast Cancer |
title | Bilateral Inflammatory Breast Cancer That Developed Two Years after Treatment for Triple-negative Breast Cancer |
title_full | Bilateral Inflammatory Breast Cancer That Developed Two Years after Treatment for Triple-negative Breast Cancer |
title_fullStr | Bilateral Inflammatory Breast Cancer That Developed Two Years after Treatment for Triple-negative Breast Cancer |
title_full_unstemmed | Bilateral Inflammatory Breast Cancer That Developed Two Years after Treatment for Triple-negative Breast Cancer |
title_short | Bilateral Inflammatory Breast Cancer That Developed Two Years after Treatment for Triple-negative Breast Cancer |
title_sort | bilateral inflammatory breast cancer that developed two years after treatment for triple-negative breast cancer |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424078/ https://www.ncbi.nlm.nih.gov/pubmed/35022341 http://dx.doi.org/10.2169/internalmedicine.7786-21 |
work_keys_str_mv | AT kawaguchiyuta bilateralinflammatorybreastcancerthatdevelopedtwoyearsaftertreatmentfortriplenegativebreastcancer AT kubasayaka bilateralinflammatorybreastcancerthatdevelopedtwoyearsaftertreatmentfortriplenegativebreastcancer AT moritamichi bilateralinflammatorybreastcancerthatdevelopedtwoyearsaftertreatmentfortriplenegativebreastcancer AT mengxiangyue bilateralinflammatorybreastcancerthatdevelopedtwoyearsaftertreatmentfortriplenegativebreastcancer AT hayashihiroko bilateralinflammatorybreastcancerthatdevelopedtwoyearsaftertreatmentfortriplenegativebreastcancer AT kobayashikazuma bilateralinflammatorybreastcancerthatdevelopedtwoyearsaftertreatmentfortriplenegativebreastcancer AT adachitomohiko bilateralinflammatorybreastcancerthatdevelopedtwoyearsaftertreatmentfortriplenegativebreastcancer AT hidakamasaaki bilateralinflammatorybreastcancerthatdevelopedtwoyearsaftertreatmentfortriplenegativebreastcancer AT itohshinichiro bilateralinflammatorybreastcancerthatdevelopedtwoyearsaftertreatmentfortriplenegativebreastcancer AT kanetakakengo bilateralinflammatorybreastcancerthatdevelopedtwoyearsaftertreatmentfortriplenegativebreastcancer AT eguchisusumu bilateralinflammatorybreastcancerthatdevelopedtwoyearsaftertreatmentfortriplenegativebreastcancer |